Multistability in a model for CTL response to HTLV-I infection and its implications to HAM/TSP development and prevention
- PMID: 20041353
- PMCID: PMC4758685
- DOI: 10.1007/s11538-009-9465-z
Multistability in a model for CTL response to HTLV-I infection and its implications to HAM/TSP development and prevention
Abstract
Human T-cell leukaemia/lymphoma virus type I (HTLV-I) is a retrovirus that has been identified as the causative agent of HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP) and other illnesses. HTLV-I infects primarily CD4(+) T cells and the transmission occurs through direct cell-to-cell contact. HAM/TSP patients harbor higher proviral loads in peripheral blood lymphocytes than asymptomatic carriers. Also, HAM/TSP patients exhibit a remarkably high number of circulating HTLV-I-specific CD8(+) cytotoxic T lymphocytes (CTLs) in the peripheral blood. While CTLs have a protective role by killing the infected cells and lowering the proviral load, a high level of CTLs and their cytotoxicity are believed to be a main cause of the development of HAM/TSP. A mathematical model for HTLV-I infection of CD4(+) T cells that incorporates the CD8(+) cytotoxic T-cell (CTL) response is investigated. Our mathematical analysis reveals that the system can stabilize at a carrier steady-state with persistent viral infection but no CTL response, or at a HAM/TSP steady-state at which both the viral infection and CTL response are persistent. We also establish two threshold parameters R(0) and R(1), the basic reproduction numbers for viral persistence and for CTL response, respectively. We show that the parameter R(1) can be used to distinguish asymptomatic carriers from HAM/TSP patients, and as an important control parameter for preventing the development of HAM/TSP.
Figures
Similar articles
-
Human T cell lymphotropic virus type I (HTLV-I)-specific CD4+ T cells: immunodominance hierarchy and preferential infection with HTLV-I.J Immunol. 2004 Feb 1;172(3):1735-43. doi: 10.4049/jimmunol.172.3.1735. J Immunol. 2004. PMID: 14734756
-
Increased HTLV type 1 tax specific CD8+ cells in HTLV type 1-asociated myelopathy/tropical spastic paraparesis: correlation with HTLV type 1 proviral load.AIDS Res Hum Retroviruses. 2000 Nov 1;16(16):1705-9. doi: 10.1089/08892220050193182. AIDS Res Hum Retroviruses. 2000. PMID: 11080814
-
Short communication an interferon-γ ELISPOT assay with two cytotoxic T cell epitopes derived from HTLV-1 tax region 161-233 discriminates HTLV-1-associated myelopathy/tropical spastic paraparesis patients from asymptomatic HTLV-1 carriers in a Peruvian population.AIDS Res Hum Retroviruses. 2011 Nov;27(11):1207-12. doi: 10.1089/AID.2011.0029. Epub 2011 May 9. AIDS Res Hum Retroviruses. 2011. PMID: 21453202
-
HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) inflammatory network.Inflamm Allergy Drug Targets. 2008 Jun;7(2):98-107. doi: 10.2174/187152808785107642. Inflamm Allergy Drug Targets. 2008. PMID: 18691139 Review.
-
Human T-lymphotropic virus type 1 (HTLV-1) and cellular immune response in HTLV-1-associated myelopathy/tropical spastic paraparesis.J Neurovirol. 2020 Oct;26(5):652-663. doi: 10.1007/s13365-020-00881-w. Epub 2020 Jul 23. J Neurovirol. 2020. PMID: 32705480 Free PMC article. Review.
Cited by
-
Inhibitory killer cell immunoglobulin-like receptors strengthen CD8+ T cell-mediated control of HIV-1, HCV, and HTLV-1.Sci Immunol. 2018 Nov 9;3(29):eaao2892. doi: 10.1126/sciimmunol.aao2892. Sci Immunol. 2018. PMID: 30413420 Free PMC article.
-
Modeling brain lentiviral infections during antiretroviral therapy in AIDS.J Neurovirol. 2017 Aug;23(4):577-586. doi: 10.1007/s13365-017-0530-3. Epub 2017 May 16. J Neurovirol. 2017. PMID: 28512685
-
Stability of an HTLV-HIV coinfection model with multiple delays and CTL-mediated immunity.Adv Differ Equ. 2021;2021(1):270. doi: 10.1186/s13662-021-03416-7. Epub 2021 May 25. Adv Differ Equ. 2021. PMID: 34054935 Free PMC article.
-
Dynamics of HIV-1/HTLV-I Co-Infection Model with Humoral Immunity and Cellular Infection.Viruses. 2022 Aug 4;14(8):1719. doi: 10.3390/v14081719. Viruses. 2022. PMID: 36016341 Free PMC article.
-
Modeling and analysis of a within-host HIV/HTLV-I co-infection.Bol Soc Mat Mex. 2021;27(2):38. doi: 10.1007/s40590-021-00330-6. Epub 2021 Mar 29. Bol Soc Mat Mex. 2021. PMID: 33814640 Free PMC article.
References
-
- Asquit B, Bangham CRM. Quantifying HTLV-I dynamics. Immunol Cell Biol. 2007;85:280–286. - PubMed
-
- Bangham CMR. The immune response to HTLV-I. Curr Opin Immunol. 2000;12:397–402. - PubMed
-
- Bangham CR, Meekings K, Toulza F, Nejmeddine M, Majorovits E, Asquith B, Taylor GP. The immune control of HTLV-1 infection: selection forces and dynamics. Front Biosci. 2009;14:2889–2903. - PubMed
-
- Cann AJ, Chen ISY. Human T-cell leukemia virus type I and II. In: Fields BN, Knipe DM, Howley PM, editors. Fields Virology. Lippincott-Raven Publishers; 1996. pp. 1849–1880.
-
- Clark DR, De Boer RJ, Wolthers KC, Miedema F. T cell dynamics in HIV-1 infection. In: Dixon FJ, editor. Advances in Immunology. Academic Press; San Diego: 1999. pp. 301–327. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous